VIRxSYS Corp — Form D/A
VIRxSYS Corp of GAITHERSBURG, MD, a company, filed a Form D amendment with the SEC on 2010-04-12. The offering totals $45.0M, of which $9.8M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2010-04-12
- Form: D/A
- Accession: 0001081596-10-000001
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $45.0M
- Amount sold: $9.8M
- Remaining: $35.2M
- Minimum investment: $5K
- Investors: 114
- Date of first sale: 2009-10-27
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-44971
Issuer
- Name: VIRxSYS Corp
- CIK: 0001081596
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 200 PERRY PARKWAY, GAITHERSBURG, MD, 20877
- Phone: 301-987-0480
Officers, directors & promoters (14)
| Name | Role | Location |
|---|
| Riku Rautsola | Director | Gaithersburg, MD |
| Riku Rautsola | Executive Officer | Gaithersburg, MD |
| Gerard Fleury | Executive Officer | Houston, TX |
| WILLIAM TURNER | Director | Boston, MA |
| Robert Ackmann | Executive Officer | Mesa, AZ |
| William Sick | Director | Gaithersburg, MD |
| William McIntosh | Director | Gaithersburg, MD |
| James Kehoe | Director | Gaithersburg, MD |
| Prince Zachariah | Director | Gaithersburg, MD |
| Lawrence Michaelis | Director | Gaithersburg, MD |
| Lawrence Michaelis | Executive Officer | Gaithersburg, MD |
| John Phair | Director | Gaithersburg, MD |
| Franz Schmadl | Director | Gaithersburg, MD |
| Helmer Agersborg | Director | Gaithersburg, MD |
Other filings by this issuer (3)
More